Page last updated: 2024-08-21

lactulose and Cancer of Prostate

lactulose has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anthony, DC; Glinskii, OV; Glinsky, GV; Glinsky, VV; Mawhinney, TP; Mossine, VV; Pienta, KJ; Sud, S1
Famularo, G; Grieco, A; Miele, L; Minisola, G1

Other Studies

2 other study(ies) available for lactulose and Cancer of Prostate

ArticleYear
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.
    Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:1

    Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Biomimetic Materials; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Galectin 3; Humans; Lactulose; Leucine; Male; Mice; Mice, SCID; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2012
Fulminant liver failure caused by cyproterone.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:9

    Topics: Aged; Alanine Transaminase; Androgen Antagonists; Cyproterone; Gastrointestinal Agents; Glutamyl Aminopeptidase; Humans; Lactulose; Liver; Liver Failure, Acute; Liver Function Tests; Male; Prednisolone; Prostatic Neoplasms; Treatment Outcome

2005